Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A pectin-type acidic polysaccharides from Coix lachryma-jobi L. seeds alleviated depression-like behavior by modulating microbiota-gut-brain axis in CRS-induced rats.

Created on 17 Nov 2026

Authors

Qianqian Yang, Lina Xu, Hanli Ye, Xingli Liu, Qinghai Zhang, Zhoubing Huang, Junxiao Pang, Dali Sun

Published in

Carbohydrate polymers. Volume 393. Pages 125934. Dec 01, 2026. Epub Oct 12, 2026.

Abstract

Coix lachryma-jobi L. is a traditional Chinese medicinal and edible resource with multiple nutritional values. However, the effect of Coix polysaccharide on depression and its underlying mechanism were still unclear. In this study, a polysaccharide (CSP-A) was isolated from Coix lachryma-jobi L. seeds with molecular weight of 15.625 kDa. The backbone of CSP-A was composed of →4)-α-D-Glcp-(1→,→4)-GlcAp-(1→, and→3)-Galp-(1 → with side chains containing Rhap-(1→, Manp-(1→, and Galp-(1 → which was further identified as a pectin-type acidic heteropolysaccharide with homogalacturonan (HG) and rhamnogalacturonan-I (RG-I) domains. Animal experiments demonstrated that CSP-A significantly ameliorated CRS-induced depressive-like behaviors by remodeling the imbalance of gut microbiota, recovered SCFA levels, and mitigated colonic pathological damage and inflammation induced by CRS treated rats. Moreover, CSP-A notably restored the disturbed metabolic profiles associated with nervous diseases. Based on its structural characteristics, it was supposed that CSP-A may act as prebiotics increasing the activities of beneficial bacteria, enhancing SCFAs production, activating AhR/CYP1A1/BDNF signaling pathway, and ultimately alleviating depressive-like behaviors. This work reported a new type of polysaccharide from Coix lachryma-jobi L. seeds and its antidepressant mechanism, highlighting its potential candidate as a new psychiatric drug.

PMID:
43039537
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement